- Home
- THM vs ACIU Comparison
THM vs ACIU Comparison
Compare THM & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THM
- ACIU
- Stock Information
- Founded
- THM 1978
- ACIU 2003
- Country
- THM Canada
- ACIU Switzerland
- Employees
- THM N/A
- ACIU N/A
- Industry
- THM
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- THM
- ACIU Health Care
- Exchange
- THM Nasdaq
- ACIU Nasdaq
- Market Cap
- THM 234.9M
- ACIU 213.3M
- IPO Year
- THM N/A
- ACIU 2016
- Fundamental
- Price
- THM $1.47
- ACIU $2.48
- Analyst Decision
- THM
- ACIU Strong Buy
- Analyst Count
- THM 0
- ACIU 2
- Target Price
- THM N/A
- ACIU $10.00
- AVG Volume (30 Days)
- THM 496.8K
- ACIU 136.3K
- Earning Date
- THM 11-06-2025
- ACIU 11-04-2025
- Dividend Yield
- THM N/A
- ACIU N/A
- EPS Growth
- THM N/A
- ACIU N/A
- EPS
- THM N/A
- ACIU N/A
- Revenue
- THM N/A
- ACIU $36,362,036.00
- Revenue This Year
- THM N/A
- ACIU N/A
- Revenue Next Year
- THM N/A
- ACIU $1,022.98
- P/E Ratio
- THM N/A
- ACIU N/A
- Revenue Growth
- THM N/A
- ACIU 86.71
- 52 Week Low
- THM $0.40
- ACIU $1.43
- 52 Week High
- THM $1.67
- ACIU $3.98
- Technical
- Relative Strength Index (RSI)
- THM 52.95
- ACIU 61.52
- Support Level
- THM $1.45
- ACIU $2.35
- Resistance Level
- THM $1.62
- ACIU $2.59
- Average True Range (ATR)
- THM 0.13
- ACIU 0.15
- MACD
- THM -0.01
- ACIU 0.03
- Stochastic Oscillator
- THM 40.94
- ACIU 79.32
About THM International Tower Hill Mines Ltd. (Canada)
International Tower Hill Mines Ltd is a mining company. It is engaged in the acquisition, exploration, and development of mineral properties. The company holds interests in an exploration project namely the Livengood Gold Project. It is located in northwest of Fairbanks, Alaska in the Tolovana mining district within the Tintina gold belt. The project property consists of land leased from the Alaska Mental Health Trust, several smaller private mineral leases, Alaska state mining claims purchased or located by the company, and the patented ground held by the company.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.